title: Prolactin specifically regulates citrate oxidation and m-aconitase of rat prostate epithelial cells.
abstract: The prostate gland of many animals, including humans, produces and secretes extremely high levels of citrate. To achieve this function, prostate secretory epithelial cells possess unique metabolic properties that permit accumulation and ultimate secretion (net citrate production) of citrate. Mounting evidence continues to support the concept that prostate epithelial cells possess a limiting mitochondrial (m)-aconitase activity that minimizes citrate oxidation and results in the accumulation of citrate synthesized by the cells. Recent studies have revealed that prolactin (PRL) stimulates net citrate production of rat lateral prostate (RLP). The mechanism of this PRL effect has not been established. The current studies were concerned with the possibility that PRL might be involved in the regulation of citrate oxidation and m-aconitase of prostate cells. Studies were conducted with RLP, RVP (rat ventral prostate), RDP (rat dorsal prostate), and kidney cells. The results showed that PRL in vitro and in vivo decreased citrate utilization and the level of m-aconitase in RLP cells, and conversely increased citrate utilization and m-aconitase in RVP cells. Furthermore, PRL had no effect on either RDP or kidney cells. The effects of PRL on both citrate utilization and m-aconitase of RLP and RVP were abolished by cycloheximide and actinomycin. Mitochondrial studies revealed that PRL decreased citrate oxidation of RLP and increased citrate oxidation of RVP, but had no effect on isocitrate oxidation. In conclusion, these studies establish that PRL has a physiological role in the regulation of citrate oxidation in prostate, and that this action is associated with PRL regulation of the biosynthesis of m-aconitase. Furthermore, the effects of PRL are cell-specific and targeted at m-aconitase.
authors.affiliation: Department of Physiology, University of Maryland Dental School, Baltimore 21201, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Liu
authors.forename: L C
authors.initials: LC
authors.lastname: Costello
authors.forename: R B
authors.initials: RB
authors.lastname: Franklin
mesh_terms: D000154:Aconitate Hydratase / Q000378:metabolism*; D000818:Animals; D015153:Blotting, Western; D001971:Bromocriptine / Q000494:pharmacology; D002951:Citrates / Q000378:metabolism*; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004847:Epithelial Cells; D004848:Epithelium / Q000201:enzymology / Q000378:metabolism; D006727:Hormone Antagonists / Q000494:pharmacology; D007668:Kidney / Q000166:cytology / Q000201:enzymology / Q000378:metabolism; D008297:Male; D008928:Mitochondria / Q000201:enzymology / Q000648:ultrastructure; D010084:Oxidation-Reduction; D011388:Prolactin / Q000494:pharmacology* / Q000502:physiology; D011467:Prostate / Q000166:cytology / Q000201:enzymology* / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D002951:Citrates; D006727:Hormone Antagonists; D003609:Dactinomycin; D001971:Bromocriptine; D011388:Prolactin; D003513:Cycloheximide; D000154:Aconitate Hydratase